Priming Cancer to Reduce Side-Effects and Enhance Tumour Control in Radiotherapy

"We have discovered an ability to manipulate cancer cells’ properties with metal nanoparticles to make them more vulnerable to radiotherapy and certain chemotherapies... Not only would this concept benefit treatment of primary tumours, but it will also combat metastatic cancers treated with radiomimetic chemotherapy or targeted alpha/beta therapies. This Pioneering Grant project will stand as the first pre-clinical step in this realisation, taking this pioneering concept into a pre-clinical setting."

- A/Prof. Ivan Kempson, University of South Australia